Dexcom’s CEO claims company has a ‘compelling’ case for broader CGM use

Dexcom’s CEO claims company has a ‘compelling’ case for broader CGM use

Source: 
MedCity News
snippet: 

In a wide-ranging interview, Dexcom’s CEO shared more about the company’s push to prove its continuous glucose monitor can be used both for patients with Type 1 and Type 2 diabetes, and how the device-maker is handling a growing number of competitors.